Page 5 - Pharmaceutical Companies

GMM Pfaudler says ready to respond to charges on unusual trades during OFS

The stock continues to fall, and is down over 36 per cent since September 15

Export boost to help pharma sector come out unscathed from Covid-19: CRISIL

Exports and domestic formulations account for an almost equal share in the Rs 2.8-trillion domestic pharma sector, CRISIL said

Gilead nears deal to buy Immunomedics for more than $20 billion: Report

Discussions between Gilead and Immunomedics were initially centered around a partnership before shifting to a full-fledged takeover negotiation

Zydus Cadila gets approval from USFDA for muscle relaxant injection

Drugfirm Zydus Cadila has received final approval from the US health regulator to market Cisatracurium BesylateInjection, a muscle relaxant given before general anaesthesia

Covid-19 prescription: Pharma players shift their focus over the counter

The pandemic pushes pharma companies to look at drugs that held promise in transitioning to over the counter segment

Firms and lenders provisions for Covid-related losses cross Rs 27,000 cr

Inventory, impairment losses also run into thousands of crores across March and June, Business Standard analysis shows

Chemist body warns against Amazon's entry into online pharmacy space

The letter has also been addressed to Prime Minister Narendra Modi, Union Home Minister Amit Shah and other top ministers and government officials

Gilead puts $2,340 price tag for coronavirus drug, faces criticism

The maker of a drug shown to shorten recovery time for severely ill patients says it will charge $2,340 for a typical treatment course for people covered by govt health programmes in the US

Atrimed Pharma launch 'Plant Science' range hand sanitiser to join the fight against COVID-19 with subsidised pricing

Atrimed Pharma launch 'Plant Science' range hand sanitiser to join the fight against COVID-19 with subsidised pricing

Lincoln Pharma gets entry into Europe, will sell derma, gastro drugs

Receives Germany's GMP certification for its Khatraj plant, can sell to all 27 EU markets

Four in a lift, facing the wall: Office etiquette in Covid-19 times

The second of a 3-part series discusses precautions taken by firms to keep employees safe

Surge in demand for preventive drugs seen post lockdown, Ayurveda in focus

Country is testing to see if herbal medicines such as ashwagandha can act as preventive instead of HCQ for Covid-19

Covid-19 impact: Indian firms look to fill in for US' Famotidine crunch

Some see this as an opportunity for Indian firms like Alembic, Aurobindo who make both the bulk drug and the formulation

Taking a nap, playing ludo: Gujarat pharma hub hit by near-zero exports

Companies finding it tough to source raw materials amid the lockdown

Shot in the arm: Pharma sales clock double-digit growth in February

Amid Coronavirus fears, sales of antibiotics, paracetamol, and respiratory drugs see a spike

'Drugs imported from unregistered dealers cannot be sold to local buyers'

In my opinion, the shipments made within the original or extended EO period can be counted towards discharge of EO, regardless of when you made the application for EO extension

Dr Reddy's to acquire part of Wockhardt's India business for Rs 1,850 crore

The agreement comprises a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, and dermatology.

Govt may impose anti-dumping duty on a Chinese medicine for infections

Aarti Drugs Ltd has filed an application before the directorate for investigation into the imports from the neighbouring country

Sun Pharma gets partial relief from US court in litigation on generic drugs

Shares of the company on Monday ended 2.18 per cent lower at Rs 440 apiece on the BSE

Biocon to set up R&D facility in India to boost biosimilars development

Biocon has acquired some assets from Pfizer Healthcare to set up its second R&D plant in India